# GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Source: https://onco.cc/trials/nct04083599/  
OnCo record `nct04083599` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of Pembrolizumab, Cisplatin, Carboplatin in non-small-cell lung cancer and small-cell lung cancer, run by Genmab, active and no longer recruiting.

## Summary

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors is a phase 1/2 interventional study registered as NCT04083599 by Genmab, with 350 participants enrolled, started 2019-09-17 and due to reach its primary completion in 2025-12-30. Interventions recorded: GEN1042, Pembrolizumab, Cisplatin, Carboplatin, 5-FU. Conditions listed: Malignant Solid Tumor, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Melanoma. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT04083599
- Phase: 1/2
- Setting: A First-in-Human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety and Anti-tumor Activity of GEN1042 in Subjects With Malignant Solid Tumors
- Sponsor: Genmab
- Enrolled: 350

## Sources

- ClinicalTrials.gov NCT04083599: https://clinicaltrials.gov/study/NCT04083599

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Melanoma](https://onco.cc/cancers/melanoma/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Small-cell lung cancer](https://onco.cc/cancers/sclc/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [FLOT (5-FU, leucovorin, oxaliplatin, docetaxel)](https://onco.cc/drugs/flot/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Paclitaxel / nab-paclitaxel](https://onco.cc/drugs/paclitaxel/), [Pembrolizumab](https://onco.cc/drugs/pembrolizumab/)
- companies: [Genmab](https://onco.cc/companies/genmab/)

---
JSON: https://onco.cc/api/v1/entities/nct04083599.json